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(The interferon (IFN) response represents an early host
defense mechanism against viral infections, and it is
known to be an important component of innate immunity
(Vilcek and Sen, 1996). IFNs were discovered as acid-
pH-resistant factors which were induced by treatment of
cells with heat-inactivated influenza virus and which
were able to inhibit (interfere with) virus replication
(Isaacs and Lindenmann, 1957). Type I IFNs are typically
secreted by eukaryotic cells in response to viral infec-
tion, leading to the stimulation of signal transduction
pathways involved in the establishment of an antiviral
state (for recent reviews, see Imada and Leonard, 2000;
Stark et al., 1998). Type II IFN or IFNg is an important
regulator of the cellular immune response and it is se-
creted by cells of lymphoid origin in response to various
cytokine stimuli. The type I IFN genes consist of IFNb
and several IFNa subtypes. All type I IFN proteins rec-
gnize the same receptor, IFNAR, on the surface of
ukaryotic cells within the same organism. Binding of
ype I IFN to its receptor results in the activation of two
embers of the Janus tyrosine kinase family, JAK1 and
yk2, which in turn activate (phosphorylate) STAT1 and
TAT2 transcription factors. As a consequence of phos-
horylation, STAT1 and STAT2 heterodimerize, translo-
ate to the nucleus, and associate with p48/IRF-9 to form
he IFN-stimulated gene factor-3 (ISGF3). The ISGF3
omplex binds specific DNA sequences containing IFN-
timulated regulatory elements (ISREs), promoting the
ranscription of downstream genes. Approximately 100
nd 300 genes are known to be transcriptionally stimu-
ated by IFNa and IFNb, respectively (Der et al., 1998).
Among these genes, those encoding the dsRNA-acti-
vated protein kinase (PKR), the 29,59-oligoadenylate syn-
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375thetases (2-5A synthetases), and the Mx proteins are
known to interfere with viral replication by different
mechanisms (Khabar et al., 2000). Thus, secretion of type
I IFN by virus-infected cells contributes to the induction
of an antiviral state in neighboring uninfected cells.
Although the levels of PKR increase in cells in re-
sponse to IFN, this antiviral enzyme is usually inactive
unless it binds dsRNA. The same principle applies to the
2-5A synthetases. Binding of dsRNA to PKR causes a
conformational change in this protein. As a result, PKR
dimerizes, autophosphorylates, and becomes enzymati-
cally active. A major target of the kinase activity of PKR is
the translation initiation factor eIF-2a. PKR-mediated
phosphorylation of eIF-2a leads to inactivation of this
actor and to inhibition of protein synthesis (for recent
eviews, see Gale et al., 2000; Williams, 1999). On the
ther hand, dsRNA activation of 2-5A synthetases results
n the synthesis of 2-5As, which in turn bind to and
ctivate a latent RNase (RNase L). Activated RNase L
nduces the degradation of RNAs, including mRNAs and
RNAs, also contributing to inhibition of protein synthesis
Stark et al., 1998). Finally, the IFN-induced Mx proteins
are GTPases which inhibit replication of specific groups
of viruses by mechanisms which are not well understood
(Arnheiter et al., 1996). In addition, it has become evident
from studies using triple-knockout (PKR2/2, RNase
L2/2, and Mx2/2) mice that additional IFN-regulated
genes participate in the induction of the antiviral state by
uncharacterized mechanisms (Zhou et al., 1999). Some of
these genes are known to interact with cellular compo-
nents involved in translation, RNA synthesis, cell growth,
and differentiation (Sen, 2000).
dsRNA appears to play a major role in the induction of
the IFN response upon viral infection (Jacobs and Lang-
land, 1996). dsRNAs are generated during virus infec-
tions as a result of overlapping bidirectional transcrip-
tional units in DNA viruses, highly structured secondary
structures of viral RNAs, and/or replicative intermediates
0042-6822/01 $35.00
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376 MINIREVIEWof different polarity in RNA viruses. dsRNA generated in
infected cells can trigger synthesis of IFNb and specific
FNas by the activation of different transcription factors,
ncluding the interferon regulatory factors IRF-3 and
RF-7, NF-kB, and ATF2/c-Jun (Braganc¸a and Civas, 1998;
Marie´ et al., 1998). Little is known about the mechanism
by which dsRNA activates these transcription factors. At
least in some systems, the dsRNA-mediated activation of
constitutively expressed PKR is responsible for the stim-
ulation of the NF-kB pathway (Chu et al., 1999; Gil et al.,
2000; Kumar et al., 1997; Yang et al., 1995). Activated PKR
in turn activates the IKK complex, which now phosphor-
ylates IkB. Phosphorylation targets this NF-kB inhibitor
o proteosome-mediated degradation (Ghosh et al.,
998). NF-kB released from IkB translocates to the nu-
cleus and cooperates with IRF-3/IRF-7 and ATF2/c-Jun in
the induction of transcription from the IFN-B gene (Juang
et al., 1998; Wathelet et al., 1998). Transcription factors
activated by dsRNA also directly participate in the induc-
tion of a subset of IFN-stimulated genes in the absence
of IFN (Daly and Reich, 1993). Once IFNb (and IFNa4 in
mouse cells) are secreted, interaction of these cytokines
with its receptor results in activation of the STAT–JAK
pathway and in the transcriptional stimulation of ISRE-
containing promoters. Cells primed with IFN now ex-
press high levels of proteins encoded by IFN-stimulated
genes, including the dsRNA-activated enzymes PKR and
2-5A synthetases. Viral infection of these cells results in
the rapid stimulation of these enzymes by viral dsRNA,
leading to protein synthesis inhibition and apoptosis/
death of the infected cell (Stark et al., 1998). In addition,
some of the genes encoding transcription factors which
participate in the activation of the IFN system, such as
IRF-7, are also stimulated by IFN, and this is responsible
for a positive feedback of the IFN response in cells
primed with IFN (Marie´ et al., 1998).
The type I IFN response is a powerful and immediate
antiviral host response (Guidotti and Chisari, 2000). It is
then not surprising that many viruses have evolved
mechanisms to counteract this response (Alcami and
Koszinowski, 2000; Cebulla et al., 1999; Gale and Katze,
1998; Goodbourn et al., 2000; Kalvakolanu, 1999; Ploegh,
1998). Subversion of the type I IFN system by viruses can
occur at different levels and different viruses are known
to prevent or inhibit IFN secretion, IFN-mediated signal-
ing, and/or activity of IFN-stimulated genes. DNA viruses,
such as poxviruses, herpesviruses, adenoviruses, and
papovaviruses among others, encode inhibitors of IRFs
(Juang et al., 1998; Li et al., 1998; Lubyova and Pitha,
2000; Moore et al., 1996; Ronco et al., 1998; Zimring et al.,
1998), inhibitors of NF-kB (Powell et al., 1996; Revilla et
l., 1998), homologues of IFN receptors (Symons et al.,
995), Jak inhibitors (Miller et al., 1998; Weihua et al.,
1998), STAT inhibitors (Look et al., 1998), p48 inhibitors
(Barnard and McMillan, 1999; Miller et al., 1999), and
inhibitors of PKR and/or 2-5A synthetases (Cassady etal., 1998; Chang et al., 1992; Clarke et al., 1991; Davies et
al., 1992; He et al., 1997; Mathews and Shenk, 1991).
Retroviruses, positive-strand RNA viruses, and dsRNA
viruses are also known to inhibit the type I IFN system by
several different mechanisms (Black et al., 1989; Gale et
al., 1998; Gunnery et al., 1990; Imani and Jacobs, 1988;
Langland et al., 1994; Roy et al., 1990; Taylor et al., 1999).
By contrast, negative-strand RNA virus gene products
involved in the inhibition of the type I IFN responses have
only recently been identified. This article will focus on
reviewing recent developments on our understanding of
how negative-strand RNA viruses interfere with the IFN
system, with special emphasis on the discussion of re-
cent data generated in my laboratory in collaboration
with Dr. Palese’s and Dr. Muster’s groups on the mech-
anism of inhibition of the type I IFN response by influenza
viruses.
The negative-strand RNA viruses comprise a broad
category of viruses belonging to the orthomyxovirus,
paramyxovirus, rhabdovirus, filovirus, arenavirus, bunya-
virus, and borna disease virus groups. Different nega-
tive-strand RNA viruses and even in some cases differ-
ent strains within the same virus group have different
abilities to induce IFN secretion in infected cells and/or
different sensitivities to the antiviral action of IFN (Mar-
cus et al., 1992). The development of reverse genetics
techniques allowing the genetic manipulation of nega-
tive-strand RNA viruses (Conzelmann, 1996; Garcı´a-
Sastre and Palese, 1993) made it possible to address
experimentally the influence of specific viral genes on
preventing the IFN-mediated antiviral responses of the
host. These techniques as well as recent advances in
the knowledge of the IFN system at the molecular level
have greatly contributed to the reflourishing of the field of
virus–host interactions involving the type I IFN system.
ORTHOMYXOVIRUSES: NS1 AND p58IPK PROTEINS
Influenza A virus is considered the prototype virus of
the orthomyxovirus group. Influenza viruses are impor-
tant pathogens causing significant illness and death in
humans and animals (Hayden and Palese, 1997). The
negative-strand RNA genome of influenza A virus con-
sists of eight segments which encode 10 proteins.
Among these proteins, the only nonstructural protein of
the virus, the NS1 protein, functions as an IFN antagonist
and plays a key role in preventing the type I IFN-medi-
ated antiviral response of the host during viral infection
(Fig. 1) (Garcı´a-Sastre et al., 1998b). The NS1 protein of
influenza A virus is an RNA-binding protein (Krug, 1998;
Yoshida et al., 1981). Interestingly, dsRNA is among the
RNA molecules which have been shown to be able to
bind in vitro to the NS1 protein (Hatada and Fukuda,
1992). Lu et al. were the first to show that NS1 protein
inhibits in vitro the dsRNA-mediated activation of PKR
and the subsequent inhibition of protein translation due
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377MINIREVIEWto eIF-2a phosphorylation (Lu et al., 1995). These prop-
erties are shared by the vaccinia virus E3L protein, a
known virus-encoded IFN antagonist which binds to
dsRNA (Watson et al., 1991). The E3L protein was shown
o prevent the dsRNA-mediated activation of PKR and
-5A synthetases (Jacobs and Langland, 1996; Rivas et
l., 1998), contributing to the resistance of vaccinia virus
o the antiviral effects of IFN (Chang et al., 1995). How-
ver, the IFN antagonist activity of the NS1 protein of
nfluenza A virus was not tested in vivo until 1998, when
an NS1 knockout influenza A virus was generated (Gar-
cı´a-Sastre et al., 1998b). This recombinant virus, delNS1,
was compromised in its replication and pathogenicity in
IFN-competent substrates and hosts, such as MDCK
cells, laboratory strains of mice, and 10-day-old embry-
onated chicken eggs (Garcı´a-Sastre et al., 1998b; Talon
et al., 2000b). In contrast, delNS1 virus grows efficiently
in substrates and hosts with deficiencies in the type I IFN
system (Garcı´a-Sastre et al., 1998b; Talon et al., 2000b),
such as Vero cells, lacking the type I IFN genes (Diaz et
al., 1988), STAT12/2 mice, deficient in IFN signaling
(Durbin et al., 1996; Meraz et al., 1996), and 7-day-old
mbryonated chicken eggs, with an immature type I IFN
ystem (Sekellick et al., 1990). Most significant is the fact
hat the delNS1 virus causes lethal disease in STAT12/2
ice (Garcı´a-Sastre et al., 1998b). The phenotypic rescue
f delNS1 virus in IFN-deficient substrates clearly impli-
ates the influenza virus NS1 protein in the inhibition of
he type I IFN system.
What is the mechanism of the IFN antagonist activity of
he influenza virus NS1 protein? It is possible that the
S1 protein, analogously to the E3L protein of vaccinia
irus, binds to and sequesters dsRNA generated during
irus replication, resulting in the inhibition of dsRNA-
ctivated pathways (Fig. 1). Several lines of evidence
FIG. 1. Schematic representation of antiviral pathways activated by
dsRNA and its inhibition by influenza A virus through the dsRNA-
binding properties of the viral NS1 protein and through the activation of
the cellular p58IPK protein. It should be noted that other cellular proteins
hat bind to dsRNA and that may participate in the host antiviral
esponse, such as the dsRNA-dependent adenosine deaminase
ADAR), might also be inhibited by the NS1 protein of influenza virus.upport this hypothesis. First, the RNA-binding domain
RBD) of the NS1 is required for in vitro inhibition of PKR
pLu et al., 1995). This inhibition might be exerted by a
irect interaction of NS1 with PKR (Tan and Katze, 1998).
econd, PKR is efficiently activated in cells infected with
S1 ts mutants of influenza A virus (Hatada et al., 1999)
r with delNS1 virus (Bergmann et al., 2000), but not in
ells infected with wild-type virus. Third, infection of cells
ith delNS1 virus, similarly to dsRNA treatment, results
n the activation of IRF-3 (Talon et al., 2000a) and NF-kB
(Wang et al., 2000), as well as in the subsequent activa-
tion of the IFN-B promoter (Wang et al., 2000), promoting
ynthesis of type I IFN (Talon et al., 2000a; Wang et al.,
000). This in turn induces the stimulation of ISRE-con-
aining promoters (Garcı´a-Sastre et al., 1998b), the ex-
ression of IFN-stimulated genes, and the induction of
n antiviral state which prevent replication of heterolo-
ous viruses (Salvatore et al., 2000). All these activities,
ncluding the stimulation of the IRF-3 and NF-kB tran-
scription factors which are required for IFN-B gene tran-
scription, are significantly reduced in wild-type virus-
infected cells (Talon et al., 2000a; Wang et al., 2000).
Fourth, a recombinant influenza A virus expressing only
the RBD of the NS1 protein retains the ability to prevent
NF-kB activation and IFNb expression in infected cells
(Wang et al., 2000). Fifth, expression in trans of NS1 from
a plasmid in the absence of any other influenza A virus
protein prevents the dsRNA- and virus-mediated activa-
tion of IRF-3, NF-kB, and IFNb synthesis (Talon et al.,
2000a; Wang et al., 2000). The RBD of the NS1 is both
required and sufficient for this inhibition. Sixth, the NS1
inhibits, by virtue of its dsRNA-binding properties, the
dsRNA-mediated stimulation of the enzymatic activity of
2-5A synthetases in vitro (Donelan and Garcı´a-Sastre,
2000). Seventh, the percentage of influenza A viruses
which display higher resistance to IFN action in a given
virus population correlates with the theoretical percent-
age of virions containing two or more copies of the NS
segment (and expressing higher levels of NS1 protein)
(Sekellick et al., 2000). However, despite all this evi-
dence, it is not yet clear whether the NS1 exerts its IFN
antagonistic functions by merely sequestering dsRNA or
by direct interactions with different host protein com-
plexes which may or may not be mediated by dsRNA.
The importance of the interplay between PKR and NS1
during influenza A virus infections is further underscored
by recent experiments showing that delNS1 virus re-
gains its replication properties not only in STAT12/2
mice, but also in PKR2/2 mice (Bergmann et al., 2000).
These observations also demonstrate a critical role of
PKR in antiviral responses, as has also been recently
shown by Leib et al. (2000) and Balachandran et al.
2000). The antiviral effects of PKR might be mediated by
combination of different activities, such as (i) its ability
o stimulate the synthesis of type I IFN through the
ctivation of IRF-1 (Kirchhoff et al., 1995) and of the NF-kB
athway (Chu et al., 1999; Gil et al., 2000; Kumar et al.,
1997; Yang et al., 1995), (ii) its role in Ser-phosphorylation
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378 MINIREVIEWof STAT1 (Ramana et al., 2000), (iii) its translational inhib-
itory properties as an eIF-2a kinase (Williams, 1999), and
(iv) its proapoptotic properties (Balachandran et al., 1998;
Der et al., 1997; Gil and Esteban, 2000; Takizawa et al.,
1996; Yeung et al., 1999). Intriguingly, influenza A viruses
appear to be able to inhibit the PKR-mediated phosphor-
ylation of eIF-2a by yet a second mechanism, which have
been extensively characterized by Dr. Katze’s group
(Gale and Katze, 1998; Gale et al., 2000) (Figs. 1 and 2).
Infection of cells by influenza A virus results in the
activation of a host PKR inhibitory protein, P58IPK (Lee et
l., 1990), which under normal circumstances is bound to
he protein I-P58IPK in an inactive complex (Lee et al.,
992). This complex is disrupted in influenza A virus-
nfected cells, and the released P58IPK physically inter-
acts with PKR (Gale et al., 1996; Polyak et al., 1996),
inhibiting its kinase activity by preventing PKR dimeriza-
tion (Tan et al., 1998) and/or by recruiting a cellular
chaperone, Hsp70 (Melville et al., 1999), to perform this
FIG. 2. Multiple mechanisms are used by negative-strand RNA virus
at which different negative-strand RNA viruses and their encoded prote
is a host cellular inhibitor of PKR activated during influenza A virus innhibition. Thus, influenza A virus, like vaccinia virus
Chang et al., 1992; Davies et al., 1992) and hepatitis Cirus (Gale et al., 1998; Taylor et al., 1999), appears to
ave evolved two different mechanisms to inhibit the
ntiviral enzyme PKR. It has now become clear that the
xpression of the NS1 protein in influenza A virus-in-
ected cells is essential for overcoming the type I IFN
esponses (see above). Whether P58IPK also plays an
ssential role in the inhibition of the type I IFN response
y influenza A virus is still an open question which
waits the generation and characterization of p58IPK
knock-out animals. Finally, possible interconnections
between the NS1- and P58IPK-mediated inhibition of
PKR in influenza A virus-infected cells remain to be
elucidated.
Influenza B and C viruses, like influenza A viruses, also
encode an NS1 protein from the shortest viral RNA seg-
ment. However, little or no homology is shared by the
NS1 proteins of these viruses. Interestingly, the NS1
protein of influenza B virus is also able to bind to dsRNA
and prevent the dsRNA-mediated activation of PKR in
ubvert the type I IFN system. The figure represents the different levels
ve been shown to antagonize the type I IFN system. In addition, p58IPKes to svitro (Wang and Krug, 1996). Moreover, two influenza B
virus mutants expressing truncated NS1 proteins
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379MINIREVIEWshowed a similar growth restriction in embryonated
chicken eggs as that of influenza A virus NS1 deletion
mutants (Talon et al., 2000b). Further experimental sup-
port for the role of the NS1 proteins of influenza B and C
viruses as IFN antagonists came from experiments dem-
onstrating that these proteins are able to inhibit in vitro
the dsRNA-mediated activation of 2-5A synthetases
(Donelan and Garcı´a-Sastre, 2000). Moreover, expres-
sion in trans of influenza B or C virus NS1 proteins
complements the growth of influenza A delNS1 virus
(Basler, Palese, and A.G.-S., unpublished). However, the
precise mechanism by which the NS1 protein of influ-
enza B and C viruses antagonize the type I IFN system in
infected cells is not known.
PARAMYXOVIRUSES: V AND C PROTEINS
The first viral gene in the negative-strand RNA group of
viruses which was clearly shown to be involved in an-
tagonizing the type I IFN system was the NS1 of influ-
enza A virus (Garcı´a-Sastre et al., 1998b). This observa-
ion was followed by the characterization of IFN antag-
nists encoded by several paramyxoviruses (Fig. 2).
aramyxoviruses are nonsegmented negative-strand
NA viruses and they include different human and ani-
al viruses, such as Sendai virus, parainfluenza viruses,
umps virus, SV5, Newcastle disease virus, measles
irus, canine distemper virus, Nipah virus, and respira-
ory syncytial viruses (RSV), among others. Fujii et al.
1988) showed that cells persistently infected with
umps or measles viruses have reduced levels of 2-5A
ynthetase activity. This effect correlated with an induc-
ion of STAT1 degradation in mumps virus-infected cells
Yokosawa et al., 1998), providing a rational basis for the
vasion of IFN-mediated antiviral responses by mumps
iruses. In addition, Didcock et al. (1999a) showed that
endai virus and SV5 inhibit the activation of IFN-respon-
ive genes in infected cells. This is in agreement with
esults from Yokoo et al. (1999) showing that Sendai virus
infection suppresses the antiviral action of type I IFN. It
was subsequently found that SV5 infection resulted in
targeting of STAT1 for proteosome-mediated degradation
and that expression of the SV5 structural protein V was
sufficient to induce STAT1 degradation in the absence of
other virus proteins (Didcock et al., 1999b). Strikingly,
human parainfluenza virus 2 (hPIV2) infection leads to
degradation of STAT2, and not of STAT1 (Young et al.,
2000). While elimination of STAT1 results in deficient type
I and type II IFN signaling, elimination of STAT2 only
interferes with type I IFN signaling, and this distinction
might be responsible for different biological properties
among different paramyxoviruses.
The V proteins of paramyxoviruses are expressed from
the P gene, which in addition codes for the P protein, an
important component of the viral RNA-dependent RNA
polymerase. The V and P proteins have the same amino-terminal sequence, but differ in their carboxy-termini due
to pseudo-template insertion of one or more nucleotides
in the P-encoded mRNA (Lamb and Kolakofsky, 1996).
Interestingly, inhibition of the type I IFN system by Sendai
virus appears to be mediated by the C proteins, which
are also encoded by the P gene. The C proteins of
paramyxoviruses are expressed from an ORF overlap-
ping the P ORF by translation from alternative initiation
codons (Lamb and Kolakofsky, 1996). Depending on the
use of one or more in-phase initiation codons, different
paramyxoviruses encode different numbers of C pro-
teins. In the case of Sendai virus, there are four C
proteins (C9, C, Y1, and Y2) expressed in virus-infected
cells. All these four proteins share the same carboxy-
terminal sequences. The role of the C proteins of Sendai
virus as IFN antagonists was established by experiments
using recombinant Sendai viruses expressing mutant C
proteins or containing mutations which prevented C pro-
tein expression (Garcin et al., 1999; Gotoh et al., 1999).
Wild-type Sendai virus-infected cells demonstrated re-
duced levels of STAT1 activation after IFN treatment,
resulting in a loss of IFN signaling (Garcin et al., 1999;
Gotoh et al., 1999; Young et al., 2000). By contrast, no IFN
signaling deficiencies were found in cells infected with C
mutant Sendai viruses (Garcin et al., 1999; Gotoh et al.,
1999). Inhibition of type I IFN signaling during wild-type
Sendai virus infection correlated with partial inhibition of
IFN-mediated tyrosine phosphorylation of Tyk2 (Komatsu
et al., 2000), with a reduction in serine 727-phosphory-
lated forms of STAT1 (Young et al., 2000) and with in-
creased STAT1 instability (Garcin et al., 2000). Individual
expression of all four Sendai virus C proteins was suffi-
cient to efficiently block IFN signaling, demonstrating
that these viral proteins have IFN antagonistic activities
(Garcin et al., 2000). The individual role of the four Sendai
virus C proteins, as well as of the C and V proteins of
different paramyxoviruses, in inhibiting the IFN system
during virus infections remains to be determined. Inter-
estingly, it is clear that different paramyxoviruses antag-
onize the IFN system by inhibiting different cellular com-
ponents (Fig. 2). For example, measles virus appears to
inhibit type I IFN production (Naniche et al., 2000); Sen-
dai virus, SV5, and hPIV3 block type I and type II IFN
signaling by targeting STAT1 activation; hPIV2 blocks
only type I IFN signaling by targeting STAT2 activation;
and RSV circumvents the antiviral IFN response without
affecting IFN synthesis and/or signaling (Schlender et al.,
2000; Young et al., 2000).
PNEUMOVIRUSES: NS1 AND NS2 PROTEINS
The C and/or V proteins of different paramyxoviruses,
such as Sendai virus and SV5, respectively, appear to be
involved in inhibiting the type I IFN system. However,
pneumoviruses, among the paramyxoviruses, do not ex-
press C/V proteins. By contrast, pneumoviruses, includ-
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380 MINIREVIEWing RSV, encode two nonstructural proteins, NS1 and
NS2, which are not present in the other paramyxovirus
groups (Collins et al., 1996). These proteins were found
to perform a nonessential function during RSV replica-
tion, since it was possible to obtain infectious NS1
and/or NS2 knockout RSVs (Buchholz et al., 1999; Jin et
l., 2000; Teng and Collins, 1999; Teng et al., 2000). A
ecent report from Schlender et al. (2000) demonstrated
that the NS1 and NS2 proteins of bovine RSV are in-
volved in antagonizing the type I IFN system during viral
infection by an unknown mechanism. Moreover, both
NS1 and NS2 proteins are required for mediating resis-
tance of bovine RSV or of a heterologous virus, such as
rabies virus, to the antiviral action of IFNs (Schlender et
al., 2000). These two proteins of RSV are likely to be
responsible for the ability of this virus to overcome the
IFN-induced antiviral response (Atreya and Kulkarni,
1999; Young et al., 2000).
FILOVIRUSES: VP35
Among the nonsegmented negative-strand RNA vi-
ruses, filoviruses include some of the most lethal viruses
for humans, Marburg and Ebola viruses. Interestingly,
Ebola virus infection results in a block on the ability to
respond to dsRNA and IFNs by the infected cells (Har-
court et al., 1998, 1999). Basler et al. (2000) found that the
Ebola virus VP35 protein, which appears to be the equiv-
alent of the P protein of paramyxo- and rhabdoviruses
(Mu¨hlberger et al., 1999), antagonizes the type I IFN
system. Expression of Ebola virus VP35 complemented
growth of the IFN-sensitive influenza A delNS1 virus in
IFN-competent cells. Expression of VP35 was also re-
sponsible for a block in dsRNA- and virus-mediated stim-
ulation of the IFNb promoter and of an ISRE-containing
promoter in human cells (Basler et al., 2000).
BUNYAVIRUSES: NSs PROTEINS
Bunyaviruses are three-segmented negative-strand
RNA viruses. As with orthomyxoviruses, paramyxovi-
ruses, and filoviruses, these viruses also seem to inhibit
the type I IFN system. Haller et al. (2000) have recently
found that attenuated isolates of Rift valley virus, a bun-
yavirus, differing from wild-type virus in their nonstruc-
tural NSs proteins, regain virulence and high levels of
replication in IFNAR2/2 mice. Moreover, high levels of
type I IFN production were induced in mice infected with
the attenuated viruses, but not in wild-type virus-infected
mice (Haller et al., 2000). Thus, the NSs protein of Rift
valley fever virus most likely plays a role in inhibiting the
type I IFN system during viral infection. Weber et al.
generated a recombinant Bunyamwera virus, also a bun-
yavirus, which is deficient in NSs production (Weber et
al., 2000). The NSs knockout virus, and not the wild-type
virus, induced the activation of IRF-3 and NF-kB tran-
cription factors and the activation of the IFN-B promoter,emonstrating an IFN antagonistic function of the NSs
rotein of Bunyamwera virus (Weber et al., 2000).
VIRUS-INDUCED SHUTOFF OF HOST CELL
PROTEIN SYNTHESIS
In addition to the specific mechanisms discussed
bove, negative-strand RNA viruses, as well as other
iruses, may inhibit the cellular antiviral responses
hrough a generalized inhibition of host cell protein syn-
hesis. Shutoff of cell protein synthesis is very efficiently
nduced by several negative-strand RNA viruses, such as
SV and influenza viruses, by mechanisms which are still
oorly understood. Since the activation of the IFN-medi-
ted antiviral response requires the induction of expres-
ion of different host factors, a general shutoff of cellular
rotein synthesis is likely to contribute to the evasion of
he type I IFN system by viruses. In this respect, it has
een shown that the VSV matrix protein inhibits host
ranscription (Ahmed and Lyles, 1998; Black and Lyles,
992), including the transcription from the human IFN-B
romoter (Ferran and Lucas-Lenard, 1997).
CONCLUDING REMARKS
Research studies conducted in the past 3 years and
iscussed above have shown that most negative-strand
NA viruses encode IFN antagonists. Remarkably, these
iruses have evolved independent and diverse mecha-
isms to antagonize the IFN system (Fig. 2). These mech-
nisms are most likely the result of a coevolution be-
ween viruses and hosts and, in most cases, do not
ppear to completely abrogate the type I IFN antiviral
esponse in the host. Recent advances in reverse genet-
cs techniques (Conzelmann, 1996; Fodor et al., 1999;
eumann et al., 1999) and in the generation of knockout
nimals in different IFN pathways, as well as of trans-
enic animal models of infection (Rall et al., 2000), will
greatly facilitate future studies aimed at understanding
the virus–host interactions leading to the inhibition of the
IFN system. These interactions seem to play a critical
role in viral pathogenicity, immunogenicity, persistence,
and tissue/host tropism (Balachandran et al., 2000; Did-
cock et al., 1999a; Durbin et al., 2000; Garcı´a-Sastre et al.,
1998a). Most likely, IFN antagonist genes will also be
identified in rhabdoviruses, hantaviruses, arenaviruses,
and borna disease viruses. In addition, rationally engi-
neered viruses with deletions/modification in their IFN
antagonist genes might be suitable live attenuated vac-
cines (Talon et al., 2000b). Finally, these recently identi-
fied viral encoded IFN antagonists among the negative-
strand RNA viruses represent promising targets for novel
antiviral therapies. Compounds inhibiting the activity
of these IFN antagonists should restore innate host
defense mechanisms resulting in inhibition of virus
replication.
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